Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04258020 · ClinicalTrials.gov registry record · NA
Postextubation Management in Patients at Risk for Extubation Failure
A NA study, sponsored by OhioHealth.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04258020: Clinical Trial NA study, sponsored by OhioHealth.
NCT04258020 is a NA study that was terminated before completion, run by OhioHealth. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04258020, a NA study, was terminated before completion, sponsored by OhioHealth.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
At the time of weaning from mechanical ventilation, patients with heart and/or lung conditions will be given oxygen support with alternating bilevel positive airway pressure (BiPAP; oxygen via face mask) and heated high flow nasal cannula oxygen (HFNC; oxygen via nasal cannula) to see if this method reduces the likelihood of re-intubation.
Primary Outcome
The number of patients who require re-intubation
Interventions
- DEVICE HFNC
- DEVICE BiPAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-02-11 |
| Est. Completion | 2020-04-02 |
| Phase | NA |
Why NCT04258020 stopped before completion
NCT04258020 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which HFNC is the first listed.
NCT04258020 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04258020 about?
NCT04258020 is a clinical study titled "Postextubation Management in Patients at Risk for Extubation Failure". At the time of weaning from mechanical ventilation, patients with heart and/or lung conditions will be given oxygen support with alternating bilevel positive airway pressure (BiPAP; oxygen via face mask) and heated high flow nasal cannula oxygen (HFNC; oxygen via nasal cannula) to see if this method...
What is the current status of trial NCT04258020?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2020-02-11. Estimated completion is 2020-04-02.
What interventions are being tested in trial NCT04258020?
The interventions under investigation include: HFNC (DEVICE), BiPAP (DEVICE).
Who is sponsoring clinical trial NCT04258020?
This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04258020's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI